Trial Outcomes & Findings for Effects of Deployment Exposures on Cardiopulmonary and Autonomic Function (NCT NCT01754922)
NCT ID: NCT01754922
Last Updated: 2017-02-28
Results Overview
Forced expiratory volume in 1 second (FEV1) measured before and after an exercise challenge
COMPLETED
50 participants
Pre/post exercise; cross-sectional
2017-02-28
Participant Flow
Participant milestones
| Measure |
Exposed
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
OEF/OIF/OND Veterans deployed to regions other than Southwest Asia
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
18
|
|
Overall Study
COMPLETED
|
32
|
17
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
| Measure |
Exposed
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
OEF/OIF/OND Veterans deployed to regions other than Southwest Asia
|
|---|---|---|
|
Overall Study
Adverse Event
|
0
|
1
|
Baseline Characteristics
Effects of Deployment Exposures on Cardiopulmonary and Autonomic Function
Baseline characteristics by cohort
| Measure |
Exposed
n=32 Participants
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
n=18 Participants
Veterans deployed to regions other than Iraq or Afghanistan or non-deployed
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
34.8 years
STANDARD_DEVIATION 8.1 • n=5 Participants
|
33.2 years
STANDARD_DEVIATION 9.7 • n=7 Participants
|
34.6 years
STANDARD_DEVIATION 8.7 • n=5 Participants
|
|
Gender
Female
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Gender
Male
|
26 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
23 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
32 participants
n=5 Participants
|
18 participants
n=7 Participants
|
50 participants
n=5 Participants
|
|
Tobacco Pack Years
|
1.45 Pack Years
STANDARD_DEVIATION 3.42 • n=5 Participants
|
1.65 Pack Years
STANDARD_DEVIATION 5.2 • n=7 Participants
|
1.5 Pack Years
STANDARD_DEVIATION 4.08 • n=5 Participants
|
PRIMARY outcome
Timeframe: Pre/post exercise; cross-sectionalForced expiratory volume in 1 second (FEV1) measured before and after an exercise challenge
Outcome measures
| Measure |
Exposed
n=32 Participants
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
n=18 Participants
Veterans deployed to regions other than Iraq and Afghanistan or non-deployed
|
|---|---|---|
|
FEV1
Pre-Exercise FEV1
|
0.94 percentage of predicted normal values
Standard Deviation .16
|
1.08 percentage of predicted normal values
Standard Deviation .16
|
|
FEV1
Post-Exercise FEV1
|
0.95 percentage of predicted normal values
Standard Deviation 0.18
|
1.09 percentage of predicted normal values
Standard Deviation 0.17
|
PRIMARY outcome
Timeframe: At peak exercise; cross-sectionalPopulation: 4 participants were excluded due to failure to meet maximal exercise criteria (3 from exposed, 1 from control). Therefore, we removed these individuals from the final analysis.
Maximal oxygen consumption measured during exercise
Outcome measures
| Measure |
Exposed
n=29 Participants
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
n=17 Participants
Veterans deployed to regions other than Iraq and Afghanistan or non-deployed
|
|---|---|---|
|
VO2 Peak
|
33.79 ml/min/kg
Standard Deviation 8.6
|
34.49 ml/min/kg
Standard Deviation 10.4
|
PRIMARY outcome
Timeframe: Resting baseline; cross-sectionalPopulation: Signal quality of the the electrocardiogram was poor for 3 individuals; therefore, their data were removed from final analysis.
Ratio of low-frequency to high-frequency power for heart rate variability
Outcome measures
| Measure |
Exposed
n=29 Participants
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
n=18 Participants
Veterans deployed to regions other than Iraq and Afghanistan or non-deployed
|
|---|---|---|
|
Heart Rate Variability
|
2.02 Ratio
Standard Deviation 1.7
|
1.13 Ratio
Standard Deviation 1.1
|
Adverse Events
Exposed
Control
Serious adverse events
| Measure |
Exposed
n=32 participants at risk
Veterans deployed to OEF/OIF/OND and environmentally exposed to high levels of particulate matter
|
Control
n=18 participants at risk
OEF/OIF/OND Veterans deployed to regions other than Southwest Asia or non-deployed
|
|---|---|---|
|
Psychiatric disorders
Psychiatric emergency
|
0.00%
0/32
|
5.6%
1/18 • Number of events 1
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place